Upper Resp Tract Infection: Clinical Trials

1 completed, 1 suspended. 2 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	2	Completed 1, Suspended 1

Follow Upper Resp Tract Infection: new trials by email Literature Review of Upper Resp Tract Infection trials Research Report on Upper Resp Tract Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS Codeine, Levodropropizine, Ivy Leaves Cough Liquid - Upper Resp Tract Infection	Phase 4	Completed	Pontificia Universidad Catolica de Chile	196	2025-05-13	2025-12-03
TEM-PCR™ Prospective Clinical Utility Study TEM-PCR URI Panel, SOC/Empiric Diagnosis - Upper Resp Tract Infection	Phase 4	Suspended	Diatherix Laboratories, LLC	314	2020-03-06	2021-08-20

Narrower conditions

Respiratory Tract Infections (2)  ·  Cough (1)

Broader conditions

Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

Codeine (1)  ·  dipropizine (1)

Sponsors

Diatherix Laboratories, LLC (1)  ·  Pontificia Universidad Catolica de Chile (1)

Countries

Chile (1)  ·  United States (1)

Top investigators

Ali Hassoun, MD (1)